Human TIMP-2 Quantikine ELISA Kit
| Name | Human TIMP-2 Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DTM200 |
| Category | ELISA Kit |
| Prices | $479.00 |
| Sizes | 1 kit |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (50 uL), Serum (10 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL), Saliva (10 uL) |
| Sensitivity | 0.064 ng/mL |
| Range | 0.2 - 10 ng/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma, Saliva) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human TIMP-2 Immunoassay is a 4.5 hour solid phase ELISA designed to measure TIMP-2 levels in cell culture supernates, serum, plasma, and saliva |
| Gene | TIMP2 |
| Supplier Page | Shop |
Product images
Product References
TIMP1 and MMP9 are predictors of mortality in septic patients in the emergency - TIMP1 and MMP9 are predictors of mortality in septic patients in the emergency
Nino ME, Serrano SE, Nino DC, McCosham DM, Cardenas ME, Villareal VP, Lopez M, Pazin-Filho A, Jaimes FA, Cunha F, Schulz R, Torres-Duenas D. PLoS One. 2017 Feb 13;12(2):e0171191.
Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant - Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant
Braicu EI, Gasimli K, Richter R, Nassir M, Kummel S, Blohmer JU, Yalcinkaya I, Chekerov R, Ignat I, Ionescu A, Mentze M, Fotopoulou C, Pop C, Lichtenegger W, Sehouli J. Anticancer Res. 2014 Jan;34(1):385-91.
Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary - Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary
Braicu EI, Fotopoulou C, Chekerov R, Richter R, Blohmer J, Kummel S, Stamatian F, Yalcinkaya I, Mentze M, Lichtenegger W, Sehouli J. Cytokine. 2013 Mar;61(3):755-8.
Activation of matrix metalloproteinases following anti-Abeta immunotherapy; - Activation of matrix metalloproteinases following anti-Abeta immunotherapy;
Wilcock DM, Morgan D, Gordon MN, Taylor TL, Ridnour LA, Wink DA, Colton CA. J Neuroinflammation. 2011 Sep 9;8:115.
Increased levels of leukocyte-derived MMP-9 in patients with stable angina - Increased levels of leukocyte-derived MMP-9 in patients with stable angina
Jonsson S, Lundberg A, Kalvegren H, Bergstrom I, Szymanowski A, Jonasson L. PLoS One. 2011 Apr 29;6(4):e19340.
Abnormalities in metalloproteinase pathways and IGF-I axis: a link between birth - Abnormalities in metalloproteinase pathways and IGF-I axis: a link between birth
Sesso R, Franco MC. Am J Hypertens. 2010 Jan;23(1):6-11.
Primary human acute myelogenous leukemia cells release matrix metalloproteases - Primary human acute myelogenous leukemia cells release matrix metalloproteases
Reikvam H, Hatfield KJ, Oyan AM, Kalland KH, Kittang AO, Bruserud O. Eur J Haematol. 2010 Mar;84(3):239-51.
MMP expression and abnormal lung permeability are important determinants of - MMP expression and abnormal lung permeability are important determinants of
McKeown S, Richter AG, O'Kane C, McAuley DF, Thickett DR. Eur Respir J. 2009 Jan;33(1):77-84.
Immunomodulation by chronobiologically-based glucocorticoids treatment for - Immunomodulation by chronobiologically-based glucocorticoids treatment for
Glass-Marmor L, Paperna T, Galboiz Y, Miller A. J Neuroimmunol. 2009 May 29;210(1-2):124-7.
Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the - Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the
O'Kane CM, McKeown SW, Perkins GD, Bassford CR, Gao F, Thickett DR, McAuley DF. Crit Care Med. 2009 Jul;37(7):2242-9.